Hair loss can be traumatic and, unfortunately, extremely common. But a New Jersey doctor says he has a new treatment.

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

When it comes to achieving healthy body weight, some men might look to what’s average and use that as their goal. For ...

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Six transgender individuals, all younger than 19, sued the administration over executive orders targeting hospitals that ...

Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...

AJ Toler was taken aback by Hims’ scathing criticism of obesity in their weight-loss drug Super Bowl commercial.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hims & Hers' future growth is expected from personalized solutions, with potential to expand the subscriber base by millions.

Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...